Clinical trial
Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)
NCT02959437
Study timeline
Study start (actual)2017-02-27Date precision: day
Registry last updated2025-10-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
AzacitidineDRUG · verified · RxNorm: azacitidine
PembrolizumabDRUG · verified · RxNorm: pembrolizumab
EpacadostatDRUG
INCB057643DRUG
PembrolizumabDRUG · verified · RxNorm: pembrolizumab
EpacadostatDRUG
INCB059872DRUG
Sponsors & collaborators
Incyte Corporationlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02959437 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.